A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Autor: Gordon, Max J. 1, ∗, Dubois, Sigrid 1, Miljkovic, Milos D. 1, 2, Ng, Samuel 1, Bryant, Bonita 1, Lakhotia, Rahul 1, Melani, Christopher 1, Pittaluga, Stefania 3, Conlon, Kevin 1, Waldmann, Thomas 1, Staudt, Louis M. 1, Wilson, Wyndham H. 1, Roschewski, Mark 1
Zdroj: In Blood Neoplasia February 2025 2(1)
Databáze: ScienceDirect